ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,691,000 | -15.7% | 79,959 | -11.4% | 0.00% | 0.0% |
| Q4 2021 | $6,750,000 | +51.5% | 90,262 | +15.1% | 0.00% | 0.0% |
| Q3 2021 | $4,455,000 | +63.8% | 78,425 | +26.9% | 0.00% | +50.0% |
| Q2 2021 | $2,719,000 | -48.3% | 61,786 | -42.0% | 0.00% | -33.3% |
| Q1 2021 | $5,255,000 | +146.6% | 106,542 | +110.5% | 0.00% | +200.0% |
| Q4 2020 | $2,131,000 | -2.6% | 50,606 | +5.8% | 0.00% | -50.0% |
| Q3 2020 | $2,189,000 | +21.9% | 47,826 | +33.7% | 0.00% | +100.0% |
| Q2 2020 | $1,796,000 | -3.4% | 35,771 | -1.1% | 0.00% | -50.0% |
| Q1 2020 | $1,860,000 | +13.6% | 36,165 | +36.4% | 0.00% | +100.0% |
| Q4 2019 | $1,638,000 | -9.3% | 26,508 | -11.8% | 0.00% | 0.0% |
| Q3 2019 | $1,805,000 | -27.6% | 30,051 | +1.7% | 0.00% | -50.0% |
| Q2 2019 | $2,493,000 | -18.5% | 29,543 | -7.8% | 0.00% | -33.3% |
| Q1 2019 | $3,060,000 | +22.7% | 32,032 | -9.0% | 0.00% | +50.0% |
| Q4 2018 | $2,493,000 | -0.6% | 35,197 | +20.0% | 0.00% | 0.0% |
| Q3 2018 | $2,507,000 | -47.7% | 29,337 | -29.0% | 0.00% | -60.0% |
| Q2 2018 | $4,792,000 | +85.3% | 41,346 | +29.4% | 0.01% | +66.7% |
| Q1 2018 | $2,586,000 | +85.2% | 31,958 | +34.4% | 0.00% | +200.0% |
| Q4 2017 | $1,396,000 | +79.4% | 23,786 | +43.1% | 0.00% | 0.0% |
| Q3 2017 | $778,000 | +69.1% | 16,623 | +30.1% | 0.00% | 0.0% |
| Q2 2017 | $460,000 | +26.0% | 12,776 | +7.8% | 0.00% | 0.0% |
| Q1 2017 | $365,000 | +10.6% | 11,854 | +20.2% | 0.00% | – |
| Q4 2016 | $330,000 | +6.8% | 9,865 | -15.2% | 0.00% | – |
| Q3 2016 | $309,000 | -13.4% | 11,629 | -28.1% | 0.00% | -100.0% |
| Q2 2016 | $357,000 | -46.9% | 16,174 | -29.3% | 0.00% | 0.0% |
| Q1 2016 | $672,000 | +17.9% | 22,879 | +32.6% | 0.00% | 0.0% |
| Q4 2015 | $570,000 | -6.7% | 17,248 | +2.0% | 0.00% | 0.0% |
| Q3 2015 | $611,000 | -29.3% | 16,917 | -11.9% | 0.00% | -50.0% |
| Q2 2015 | $864,000 | +114.9% | 19,204 | +46.3% | 0.00% | +100.0% |
| Q1 2015 | $402,000 | -46.0% | 13,128 | -10.3% | 0.00% | -50.0% |
| Q4 2014 | $744,000 | -59.0% | 14,636 | -68.1% | 0.00% | -50.0% |
| Q3 2014 | $1,813,000 | +552.2% | 45,813 | +609.0% | 0.00% | +300.0% |
| Q2 2014 | $278,000 | – | 6,462 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |